These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 7542430)

  • 1. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
    Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
    AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.
    Winkelbauer FW; Nierderle B; Graf O; Prokesch R; Thurnher S; Wildling R; Lammer J
    Cardiovasc Intervent Radiol; 1995; 18(6):353-9. PubMed ID: 8591620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
    Clouse ME; Perry L; Stuart K; Stokes KR
    Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
    Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
    Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
    Diamandidou E; Ajani JA; Yang DJ; Chuang VP; Brown CA; Carrasco HC; Lawrence DD; Wallace S
    AJR Am J Roentgenol; 1998 Feb; 170(2):339-44. PubMed ID: 9456942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter chemoembolization of progressive carcinoid liver metastasis.
    Therasse E; Breittmayer F; Roche A; De Baere T; Indushekar S; Ducreux M; Lasser P; Elias D; Rougier P
    Radiology; 1993 Nov; 189(2):541-7. PubMed ID: 7692465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization.
    Diaco DS; Hajarizadeh H; Mueller CR; Fletcher WS; Pommier RF; Woltering EA
    Am J Surg; 1995 May; 169(5):523-8. PubMed ID: 7747834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil.
    Wang MQ; Duan F; Liu FY; Wang ZJ; Song P
    Abdom Imaging; 2013 Jun; 38(3):465-73. PubMed ID: 22743841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors.
    Drougas JG; Anthony LB; Blair TK; Lopez RR; Wright JK; Chapman WC; Webb L; Mazer M; Meranze S; Pinson CW
    Am J Surg; 1998 May; 175(5):408-12. PubMed ID: 9600289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors.
    Schell SR; Camp ER; Caridi JG; Hawkins IF
    J Gastrointest Surg; 2002; 6(5):664-70. PubMed ID: 12399054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic arterial chemoembolization for metastatic endocrine tumors.
    Stokes KR; Stuart K; Clouse ME
    J Vasc Interv Radiol; 1993; 4(3):341-5. PubMed ID: 8390317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in mid-gut carcinoid patients. The Norwegian carcinoid study.
    Jacobsen MB; Hanssen LE; Kolmannskog F; Schrumpf E; Vatn MH; Bergan A
    Scand J Gastroenterol; 1995 Aug; 30(8):789-96. PubMed ID: 7481548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder.
    Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA
    J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
    Jermendy G; Kónya A; Kárpáti P
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results.
    Loewe C; Schindl M; Cejna M; Niederle B; Lammer J; Thurnher S
    AJR Am J Roentgenol; 2003 May; 180(5):1379-84. PubMed ID: 12704055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal metastases to the liver: selective chemoembolization.
    Lang EK; Brown CL
    Radiology; 1993 Nov; 189(2):417-22. PubMed ID: 8210369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours.
    Dominguez S; Denys A; Madeira I; Hammel P; Vilgrain V; Menu Y; Bernades P; Ruszniewski P
    Eur J Gastroenterol Hepatol; 2000 Feb; 12(2):151-7. PubMed ID: 10741928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose, short-interval target vessel regional chemotherapy through the hepatic artery combined with transarterial embolization in gastric cancer patients with liver metastases after failure of first-line or second-line chemotherapy: a preliminary analysis.
    Chen H; Liu P; Xu HF; Wang XD; Zhu X; Gao S; Cao G; Zhu LZ; Guo JH
    Anticancer Drugs; 2014 Jan; 25(1):92-100. PubMed ID: 24185381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.